Adial Pharmaceuticals Says Entered Into Securities Purchase Agreements With Each Of Bespoke Growth Partners, 3 Entities Controlled By James Newman Jr And Keystone Capital Partners; Agrees To Sale Of Shares Totaling 700,001 Shares Of Common Stock At $3/Sha